NEW CRYSTALLINE FORM OF VEGF-R INHIBITOR

PROBLEM TO BE SOLVED: To provide a polymorphic form of 6-[2-(methyIcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole which is useful when treating abnormal cell proliferation of mammal cancer, etc. SOLUTION: The present invention provides a pharmaceutical composition containing at leas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CAMPETA ANTHONY MICHAEL, MCLAUGHLING ROBERT WILLIAM, SINGER ROBERT ALAN, CHEKAL BRIAN PATRICK
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a polymorphic form of 6-[2-(methyIcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole which is useful when treating abnormal cell proliferation of mammal cancer, etc. SOLUTION: The present invention provides a pharmaceutical composition containing at least one polymorphic form represented by formula 1 or a therapeutic or prophylactic use of such polymorphic form and a composition comprising the same. COPYRIGHT: (C)2009,JPO&INPIT